Five Phos (Rxhomeo Private Limited d.b.a. Rxhomeo, Inc)
Welcome to the PulseAid listing for the Five Phos drug offered from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Rxhomeo Private Limited d.b.a. Rxhomeo, Inc |
NON-PROPRIETARY NAME: | CALCAREA PHOSPHORICA, FERRUM PHOSPHORICUM, KALI PHOSPHORICUM, MAGNESIA PHOSPHORICA, NATRUM PHOSPHORICUM |
SUBSTANCE NAME: | TRIBASIC CALCIUM PHOSPHATE; FERROSOFERRIC PHOSPHATE; POTASSIUM PHOSPHATE, DIBASIC; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SILICON DIOXIDE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2016-04-05 |
END MARKETING DATE: | 0000-00-00 |
Five Phos HUMAN OTC DRUG Details:
Item Description | Five Phos from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc |
LABELER NAME: | Rxhomeo Private Limited d.b.a. Rxhomeo, Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3; 3; 3; 3; 3; 3([hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1) |
START MARKETING DATE: | 2016-04-05 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 15631-2351_8a640f50-ad4c-4c9f-8cfc-5fc23fafb1fc |
PRODUCT NDC: | 15631-2351 |
APPLICATION NUMBER: | |
Other TRIBASIC CALCIUM PHOSPHATE; FERROSOFERRIC PHOSPHATE; POTASSIUM PHOSPHATE, DIBASIC; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SILICON DIOXIDE Pharmaceutical Manufacturers / Labelers: